O	0	3	p21	p21	NN	B-NP
O	4	10	delays	delay	VBZ	B-VP
B-Cancer	11	16	tumor	tumor	NN	B-NP
O	17	22	onset	onset	NN	I-NP
O	23	25	by	by	IN	B-PP
O	26	38	preservation	preservation	NN	B-NP
O	39	41	of	of	IN	B-PP
B-Cellular_component	42	53	chromosomal	chromosomal	JJ	B-NP
O	54	63	stability	stability	NN	I-NP
O	63	64	.	.	.	O

O	66	69	The	The	DT	B-NP
O	70	73	p53	p53	NN	I-NP
O	74	81	protein	protein	NN	I-NP
O	82	92	suppresses	suppress	VBZ	B-VP
O	93	106	tumorigenesis	tumorigenesis	NN	B-NP
O	107	109	by	by	IN	B-PP
O	110	120	initiating	initiate	VBG	B-VP
B-Cell	121	129	cellular	cellular	JJ	B-NP
O	130	139	functions	function	NNS	I-NP
O	140	144	such	such	JJ	B-PP
O	145	147	as	as	IN	I-PP
B-Cell	148	152	cell	cell	NN	B-NP
O	153	158	cycle	cycle	NN	I-NP
O	159	165	arrest	arrest	NN	I-NP
O	166	169	and	and	CC	I-NP
O	170	179	apoptosis	apoptosis	NN	I-NP
O	180	182	in	in	IN	B-PP
O	183	191	response	response	NN	I-PP
O	192	194	to	to	TO	I-PP
O	195	198	DNA	DNA	NN	B-NP
O	199	205	damage	damage	NN	I-NP
O	205	206	.	.	.	O

O	207	208	A	A	DT	B-NP
O	209	212	p53	p53	NN	I-NP
O	213	219	mutant	mutant	NN	I-NP
O	219	220	,	,	,	O
O	221	229	p53R172P	p53R172P	NN	B-NP
O	229	230	,	,	,	O
O	231	236	which	which	WDT	B-NP
O	237	239	is	be	VBZ	B-VP
O	240	249	deficient	deficient	JJ	B-ADJP
O	250	253	for	for	IN	B-PP
O	254	263	apoptosis	apoptosis	NN	B-NP
O	264	267	but	but	CC	O
O	268	275	retains	retain	VBZ	B-VP
O	276	277	a	a	DT	B-NP
O	278	285	partial	partial	JJ	I-NP
B-Cell	286	290	cell	cell	NN	I-NP
O	291	296	cycle	cycle	NN	I-NP
O	297	303	arrest	arrest	NN	I-NP
O	304	312	function	function	NN	I-NP
O	312	313	,	,	,	O
O	314	320	delays	delay	VBZ	B-VP
B-Cancer	321	326	tumor	tumor	NN	B-NP
O	327	332	onset	onset	NN	I-NP
O	333	335	in	in	IN	B-PP
O	336	340	mice	mouse	NNS	B-NP
O	340	341	.	.	.	O

O	342	352	Remarkably	Remarkably	RB	B-ADVP
O	352	353	,	,	,	O
B-Cancer	354	363	lymphomas	lymphoma	NNS	B-NP
O	364	371	arising	arise	VBG	B-VP
O	372	374	in	in	IN	B-PP
O	375	380	Trp53	Trp53	NN	B-NP
O	380	381	(	(	(	O
O	381	385	515C	515C	NN	B-NP
O	385	386	/	/	SYM	O
O	386	390	515C	515C	NN	O
O	390	391	)	)	)	O
O	392	396	mice	mouse	NNS	B-NP
O	397	398	(	(	(	O
O	398	406	encoding	encode	VBG	B-VP
O	407	415	p53R172P	p53R172P	NN	B-NP
O	415	416	)	)	)	O
O	417	423	retain	retain	VBP	B-VP
O	424	430	stable	stable	JJ	B-NP
O	431	438	genomes	genome	NNS	I-NP
O	438	439	.	.	.	O

O	440	445	Given	Give	VBN	B-PP
O	446	449	the	the	DT	B-NP
O	450	458	dominant	dominant	JJ	I-NP
O	459	463	role	role	NN	I-NP
O	464	466	of	of	IN	B-PP
O	467	470	p21	p21	NN	B-NP
O	471	473	in	in	IN	B-PP
O	474	477	p53	p53	NN	B-NP
B-Cell	478	482	cell	cell	NN	I-NP
O	483	488	cycle	cycle	NN	I-NP
O	489	496	control	control	NN	I-NP
O	496	497	,	,	,	O
O	498	500	we	we	PRP	B-NP
O	501	508	crossed	cross	VBD	B-VP
O	509	514	Trp53	Trp53	NN	B-NP
O	514	515	(	(	(	O
O	515	519	515C	515C	NN	B-NP
O	519	520	/	/	SYM	O
O	520	524	515C	515C	NN	O
O	524	525	)	)	)	O
O	526	530	mice	mouse	NNS	B-NP
O	531	535	onto	onto	IN	B-PP
O	536	537	a	a	DT	B-NP
O	538	541	p21	p21	NN	I-NP
O	541	542	-	-	HYPH	B-NP
O	542	546	null	null	JJ	I-NP
O	547	557	background	background	NN	I-NP
O	558	560	to	to	TO	B-VP
O	561	570	determine	determine	VB	I-VP
O	571	578	whether	whether	IN	B-SBAR
O	579	582	p21	p21	NN	B-NP
O	583	586	was	be	VBD	B-VP
O	587	595	required	require	VBN	I-VP
O	596	599	for	for	IN	B-PP
O	600	611	maintaining	maintain	VBG	B-VP
B-Cellular_component	612	623	chromosomal	chromosomal	JJ	B-NP
O	624	633	stability	stability	NN	I-NP
O	634	637	and	and	CC	O
O	638	646	delaying	delay	VBG	B-VP
B-Cancer	647	652	tumor	tumor	NN	B-NP
O	653	658	onset	onset	NN	I-NP
O	658	659	.	.	.	O

O	660	664	Loss	Loss	NN	B-NP
O	665	667	of	of	IN	B-PP
O	668	671	p21	p21	NN	B-NP
O	672	682	completely	completely	RB	B-ADVP
O	683	692	abolished	abolish	VBD	B-VP
O	693	696	the	the	DT	B-NP
B-Cell	697	701	cell	cell	NN	I-NP
O	702	707	cycle	cycle	NN	I-NP
O	708	714	arrest	arrest	NN	I-NP
O	715	723	function	function	NN	I-NP
O	724	726	of	of	IN	B-PP
O	727	735	p53R172P	p53R172P	NN	B-NP
O	736	739	and	and	CC	O
O	740	751	accelerated	accelerate	VBD	B-VP
B-Cancer	752	757	tumor	tumor	NN	B-NP
O	758	763	onset	onset	NN	I-NP
O	764	766	in	in	IN	B-PP
O	767	772	Trp53	Trp53	NN	B-NP
O	772	773	(	(	(	O
O	773	777	515C	515C	NN	B-NP
O	777	778	/	/	SYM	O
O	778	782	515C	515C	NN	O
O	782	783	)	)	)	O
O	784	788	mice	mouse	NNS	B-NP
O	788	789	.	.	.	O

O	790	801	Cytogenetic	Cytogenetic	JJ	B-NP
O	802	813	examination	examination	NN	I-NP
O	814	816	of	of	IN	B-PP
O	817	822	Trp53	Trp53	NN	B-NP
O	822	823	(	(	(	O
O	823	827	515C	515C	NN	B-NP
O	827	828	/	/	SYM	B-NP
O	828	832	515C	515C	NN	I-NP
O	832	833	)	)	)	O
O	834	837	p21	p21	NN	B-NP
O	837	838	(	(	(	O
O	838	839	-	-	SYM	O
O	839	840	/	/	SYM	O
O	840	841	-	-	SYM	O
O	841	842	)	)	)	O
B-Cancer	843	851	sarcomas	sarcoma	NNS	B-NP
O	852	855	and	and	CC	I-NP
B-Cancer	856	865	lymphomas	lymphoma	NNS	I-NP
O	866	874	revealed	reveal	VBD	B-VP
O	875	885	aneuploidy	aneuploidy	NN	B-NP
O	886	889	and	and	CC	O
B-Pathological_formation	890	901	chromosomal	chromosomal	JJ	B-NP
I-Pathological_formation	902	913	aberrations	aberration	NNS	I-NP
O	914	918	that	that	WDT	B-NP
O	919	923	were	be	VBD	B-VP
O	924	930	absent	absent	JJ	B-ADJP
O	931	933	in	in	IN	B-PP
O	934	939	Trp53	Trp53	NN	B-NP
O	939	940	(	(	(	O
O	940	944	515C	515C	NN	B-NP
O	944	945	/	/	SYM	O
O	945	949	515C	515C	NN	O
O	949	950	)	)	)	O
B-Cancer	951	963	malignancies	malignancy	NNS	B-NP
O	963	964	.	.	.	O

O	965	969	Thus	Thus	RB	B-ADVP
O	969	970	,	,	,	O
O	971	974	p21	p21	NN	B-NP
O	975	982	coupled	couple	VBD	B-VP
O	983	986	p53	p53	NN	B-NP
O	986	987	-	-	HYPH	B-NP
O	987	996	dependent	dependent	JJ	I-NP
O	997	1007	checkpoint	checkpoint	NN	I-NP
O	1008	1015	control	control	NN	I-NP
O	1016	1019	and	and	CC	I-NP
O	1020	1032	preservation	preservation	NN	I-NP
O	1033	1035	of	of	IN	B-PP
B-Cellular_component	1036	1047	chromosomal	chromosomal	JJ	B-NP
O	1048	1057	stability	stability	NN	I-NP
O	1057	1058	,	,	,	O
O	1059	1062	and	and	CC	O
O	1063	1073	cooperated	cooperate	VBD	B-VP
O	1074	1078	with	with	IN	B-PP
O	1079	1088	apoptosis	apoptosis	NN	B-NP
O	1089	1091	in	in	IN	B-PP
O	1092	1103	suppressing	suppress	VBG	B-VP
B-Cancer	1104	1109	tumor	tumor	NN	B-NP
O	1110	1115	onset	onset	NN	I-NP
O	1116	1118	in	in	IN	B-PP
O	1119	1123	mice	mouse	NNS	B-NP
O	1123	1124	.	.	.	O

